Aripiprazole and Dosing
Links shared publicly online about this topic
Adding a low dose atypical antipsychotic drug to a... [Prog Neuropsychopharmacol Biol Psychiatry. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on May 19, 2010 at 2:45 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Aripiprazole antidepressant augmentation produces rapid increase in BDNF in treatment-resistant depression. http://ht.ly/1MQYN
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia. ALKS 9070, a proprietary Alkermes molecule for the treatment of schizophrenia, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY® for the treatment of a number of central nervo” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 6:00 pm By:
Alkermes Announces Positive Results From Clinical Study Of ALKS 9070 For Treatment Of Schizophrenia: Alkermes, Inc... http://bit.ly/kd2y2o
A placebo-controlled, fixed-dose study of aripipra... [J Am Acad Child Adolesc Psychiatry. 2009] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on October 3, 2009 at 2:38 pm By:
William Yates, M.D. Psychiatrist, Family Medicine Doctor, Physician, and Doctor
Aripiprazole (Abilify) reduces irritability in adolescents with autism in clinical trial. http://ow.ly/swv6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
William Yates, M.D.
Clinical Neuroscientist. Research Psychiatrist, Laureate Institute of Brain Research (laureateinstitute.org) Professor of Research, University of Oklahoma.
Advertisement
